The global market size for Chondroitin Sulfate Injection was valued at approximately USD 1.5 billion in 2023 and is projected to reach around USD 2.5 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.5%. This upward trajectory is fueled by several growth factors including an increasing prevalence of osteoarthritis and joint pain, advancements in medical research, and a growing elderly population worldwide.